Research Progress of Cell Metabolic Reprogramming Driving the Occurrence and Development of Pulmonary Fibrosis
International Journal of Clinical and Experimental Medicine Research · 02.07.2026 · 10 (4) · 291-298
DOI: 10.26855/ijcemr.2026.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Medicine Research, online erschienen am 02.07.2026. Verfasst von Ming Qi und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Pulmonary fibrosis (PF) is a brutal, progressive lung disease with a lousy prognosis. Basically, the lung tissue scars over abnormally, wrecking the structure and shut-ting down function. The core problem is a dysfunctional axis: alveolar epithelial cells keep getting injured, immune balance falls apart, and fibroblasts go into overdrive, dumping massive amounts of extracellular matrix and remodeling the organ beyond repair. Here’s the kicker: metabolic reprogramming is the engine driving this whole mess. Mitochondrial dysfunction spikes reactive oxygen species (ROS) and stabilizes hypoxia-inducible factor (HIF-1α), forcing cells to ditch oxidative phosphorylation for aerobic glycolysis. The resulting metabolites—like lactate—aren’t just fuel; they act as signaling molecules that mess with epigenetics and cell talk, locking in that pro-fibrotic phenotype. Meanwhile, busted lipid metabolism and amino acid flux feed the scarring machine. This review breaks down how metabolic rewiring fuels PF and explores whether targeting these nodes can actually stop the progression.
Zitieren
APA
Qi, M., Song, W., Sun, P., & Jiang, C. (2026). Research Progress of Cell Metabolic Reprogramming Driving the Occurrence and Development of Pulmonary Fibrosis. International Journal of Clinical and Experimental Medicine Research, 10(4), 291-298. https://doi.org/10.26855/ijcemr.2026.07.007
Vancouver
Qi M, Song W, Sun P, Jiang C. Research Progress of Cell Metabolic Reprogramming Driving the Occurrence and Development of Pulmonary Fibrosis. International Journal of Clinical and Experimental Medicine Research. 2026;10(4):291-298. doi:10.26855/ijcemr.2026.07.007
BibTeX
@article{Qi2026,
author = {Qi, Ming and Song, Wengang and Sun, Peng and Jiang, Chengyuan},
title = {Research Progress of Cell Metabolic Reprogramming Driving the Occurrence and Development of Pulmonary Fibrosis},
journal = {International Journal of Clinical and Experimental Medicine Research},
year = {2026},
volume = {10},
number = {4},
pages = {291--298},
doi = {10.26855/ijcemr.2026.07.007}
}
EUVIMED